Clinical Trial Update: Alternative in Beta Blocker Intolerance: The ABBI Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update for ABBI trial evaluating an alternative in beta blocker intolerance in coronary artery disease; study terminated with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Minneapolis Heart Institute Foundation | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED | Results posted: 2019-07-17